GLP-1 starter guide: the first 30 days

I’ve worked with somewhere north of 200 patients across their first month on a GLP-1 agonist (semaglutide, tirzepatide, the older liraglutide, and a few off-label uses I won’t get into here). The first 30 days have a recognizable shape, and most of my early conversations with new starters are about normalizing what they’re experiencing and adjusting nutrition to fit.

This post is what I’d hand a patient on day one if I had time to type it all out. It’s not medical advice; your prescriber is the person calling the actual shots, and titration decisions are theirs. But the nutritional, hydration, and tracking pieces are where I spend most of my appointment time, and that’s where I can be useful in writing.

A note on which medication. Semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have somewhat different side effect profiles (tirzepatide tends to produce slightly more dramatic appetite suppression and slightly more nausea early; semaglutide is often gentler at the start but slower to titrate). The week-by-week pattern below applies broadly to both. Liraglutide (Saxenda, Victoza) is daily-dosed rather than weekly and the curves are flatter, but the principles are similar.

Week 1: the appetite drops out

The most common day-by-day experience: injection on day one. Day one and two are usually fine, sometimes uneventful enough that patients wonder if the medication is working. By day three or four, the appetite drop is noticeable. By day five, it’s hard to miss.

What “appetite drop” actually feels like. Patients describe it as the food chatter going quiet. The afternoon snack pull weakens. The “I should probably eat” thought stops showing up at expected meal times. Some report that previously favorite foods become uninteresting or even slightly aversive. This is the medication doing what it’s designed to do.

Nausea. Common, especially day three through six. Usually mild to moderate, often manageable with smaller meals, less fat, and avoiding strong smells. If you’re vomiting more than once or twice in the first week, call your prescriber: nausea that severe is sometimes a sign the starting dose is too aggressive, and some prescribers will adjust.

Common week 1 mistakes: Skipping meals because you’re not hungry, drinking less water because you’re not thirsty, and eating high-fat comfort food because it sounds appealing (it usually makes the nausea worse).

What to actually do in week 1:

Don’t skip protein. Even if you’re not hungry, hit a protein floor of at least 0.8g per pound of goal bodyweight (roughly 1.6g/kg). For a person with a 150-pound goal weight, that’s 120g protein minimum, every day. This is non-negotiable for preserving muscle as you lose weight, and it gets harder later if you don’t establish the habit week 1.
Hydrate on a schedule, not on thirst. GLP-1s suppress thirst alongside appetite. Aim for 35 mL per kg bodyweight per day (about 75 to 100 oz for most adults). Set timers if you need to.
Eat smaller meals more often. Three large meals will trigger nausea. Five or six small protein-forward bites distributed across the day will not.
Avoid alcohol entirely for the first week. The combination of low food volume, dehydration risk, and slowed gastric emptying makes alcohol hit harder and feel worse. Some of my patients lose tolerance permanently, which is often a welcome change but worth knowing about.
Start logging now if you weren’t already. This is the easiest week to establish the habit because you’re paying close attention to food anyway.

Week 2: titration and the first weight shift

The starting dose of semaglutide (0.25 mg) and tirzepatide (2.5 mg) is deliberately sub-therapeutic. It’s an introduction dose, designed to let your gut adapt. After four weeks at starting dose, most prescribers move you up.

Some prescribers titrate faster. Some hold longer. There are reasonable arguments for both. If you’re tolerating week 1 well and your appetite suppression is already strong, slower titration is generally fine and side-effect-friendly. If you’re not feeling much appetite change at all by mid-week 2, that’s worth a conversation with your prescriber.

The first scale move. Most patients see 2 to 6 pounds down by the end of week 2. The majority of that is water and glycogen, with a small fat component. This is normal and doesn’t mean you’re “losing weight fast” in any meaningful long-term sense. The fat-loss curve doesn’t really kick in until weeks 3 and 4.

What to watch in week 2:

Continued nausea. Should be improving over week 1, not worsening. If it’s getting worse, that’s a flag.
Constipation. Very common starting week 2. Slowed gastric emptying plus reduced food volume plus reduced fluid intake equals stalled bowels. The fix is fiber (psyllium, vegetables, fruit) and water, in that order. Magnesium citrate at 200 to 400 mg before bed can help if the fiber-plus-water approach isn’t enough.
Heartburn or reflux. Some patients get this for the first time on GLP-1s, usually because food sits in the stomach longer. Smaller meals and not lying down for two hours after eating helps. If it’s persistent, talk to your prescriber about whether an acid reducer is appropriate.
Fatigue. Real, especially if you’re under-eating. The fix is calories, not coffee. If you’ve dropped from 2,200 calories a day to 1,100 because food is unappealing, that’s too steep. Aim for at least 1,200 to 1,400 minimum for women and 1,500 to 1,800 minimum for men, even with reduced appetite. Below that, fatigue and muscle loss escalate.

The Tuesday-or-Wednesday rule. Most weekly GLP-1s peak in effect about 24 to 48 hours after injection. If you inject Sunday, your strongest appetite suppression is Monday and Tuesday, with food slowly becoming more appealing toward Saturday. Plan accordingly: do your harder protein meals on the days you can stomach them.

Week 3: the rhythm settles

By week 3, most patients have a clearer sense of what their new normal looks like. Side effects from the starting dose have generally peaked and started to ease. Appetite suppression is established as a consistent backdrop rather than a novelty.

What week 3 tends to look like in practice:

Two or three “good” eating days per week where hitting protein and reasonable calories is achievable.
Two or three “low” days where you have to deliberately plan and execute small protein-forward meals because nothing sounds good.
One or two “almost normal” days where appetite returns somewhat, often later in the week before the next injection.

This is when I have patients audit: Pull up a week of logs and look at the pattern. Are you hitting your protein floor on the good days? Are you below 1,200 calories on the low days? Are you weighing in consistently?

Common week 3 patterns to address:

Protein under-hitting on low days. The most common pattern. Patients hit 80g on a nausea day when they should be hitting 110g. Solutions: protein shakes (cold, often more tolerable than hot food), Greek yogurt, cottage cheese, jerky, deli turkey, eggs. The texture and temperature you can tolerate matter as much as the macros.
Carb avoidance overshooting. Some patients accidentally drop carbs to under 50g a day because they’re not eating much of anything. This compounds the fatigue and depresses thyroid function over weeks. Aim for at least 80 to 100g of carbs a day even at low intake.
Skipping the weigh-in. The scale moves erratically on a GLP-1 due to fluid shifts, constipation, and inconsistent intake. Patients who weigh daily and react to single-day swings tend to do worse than patients who weigh three times a week and average. Weekly average is the meaningful number.

Week 4: the new normal and the first prescriber check-in

Most prescribers do a check-in around the 30-day mark, often virtual, often brief. The decisions on the table:

Titrate up to the next dose, if you’ve tolerated the starting dose and want stronger effect.
Hold at the starting dose, if appetite suppression is strong enough and side effects are present.
Hold and reassess in another month, if side effects are still problematic.

What to bring to the appointment:

Weekly average weights for the four weeks, not single-day numbers.
Average daily protein, if you’ve been tracking. If you haven’t, your prescriber will accept rough estimates.
Side effect frequency and severity, including specifics: how many days of nausea, how many vomiting episodes, how many days of constipation, sleep changes, mood changes.
Hydration estimate, in ounces per day.
Any new medication interactions. GLP-1s slow gastric emptying, which can affect absorption of oral medications. Birth control specifically: check with your prescriber.

What patients consistently underestimate at the one-month mark:

How much they’ve changed without noticing. Energy, mood, food preoccupation, and sleep are often better in ways patients don’t connect to the medication.
How much they’re still figuring out. The first month is the orientation period. Months 2 through 4 are when most of the metabolic adaptation and dose calibration actually happen.
The risk of muscle loss. If you’ve lost 8 pounds in the first month and your protein has averaged 70g a day, a meaningful fraction of that loss is lean mass. The most actionable thing you can do in month 2 is anchor the protein floor and add resistance training if you’re not already.

When to call your prescriber, not wait for the appointment

Some symptoms shouldn’t wait for the 30-day check-in. Call sooner if:

Severe, persistent vomiting beyond the first week.
Severe upper-right abdominal pain (possible gallbladder involvement; GLP-1s have an increased gallbladder event rate).
Pancreatic-pattern abdominal pain (severe, central, radiating to back).
Inability to keep fluids down for more than 24 hours.
New or worsening depression or suicidal ideation.
Vision changes (rare but documented).
Heart rate consistently elevated at rest.

These aren’t the common path. Most patients have a manageable, uneventful first month. But they’re worth knowing about so you can flag them quickly if they show up.

The first 30 days are an orientation. Your job is to figure out what eating looks like in this new physiological state, hit your protein floor every day, stay hydrated, and gather information for the conversation with your prescriber at the one-month mark. The weight loss is the byproduct of doing those things consistently. It’s not the metric to optimize against in month one.

I’ll write the month 2 through 6 follow-up later. The patterns there are different, and most of the long-term success is determined by what happens between months 2 and 6, not by what happens in month 1. But you have to get through month 1 first.

Macroline is not medical advice. Your prescriber is the only person who should be making dose, titration, and side-effect decisions about your specific case. The framework above is general guidance based on clinical experience with a varied patient population.